|
Market Closed -
Nasdaq
16:00:00 2026-11-13 EST
|
5-day change | 1st Jan Change | ||
| 121.16 USD | +2.62% |
|
+5.90% | -30.38% |
| 11-02 | Mizuho Adjusts Price Target on Insmed to $158 From $154, Keeps Outperform Rating | MT |
| 10-29 | Insmed Q3 Net Loss Narrows; Revenue Rises | MT |
| Market Cap | 26.58B 24.09B 22.28B 20.1B 37.88B 2,506B 39.22B 268B 106B 1,339B 99.75B 97.63B 4,250B | P/E 2026 * |
-73.9x | P/E 2027 * | 170x |
|---|---|---|---|---|---|
| Enterprise Value | 26.07B 23.62B 21.85B 19.71B 37.15B 2,458B 38.46B 262B 104B 1,313B 97.82B 95.74B 4,167B | EV / Sales 2026 * |
14x | EV / Sales 2027 * | 8.57x |
| Free-Float |
99.48% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| INSM | Delayed | |
| INSM | Real-time | ||
| INSM * | End-of-day quote | ||
| IM8N | End-of-day quote | ||
| IM8N | Real-time | ||
| IM8N | Real-time | ||
| IM8N | Delayed | ||
| IM8N | Delayed | ||
| 1INSM | End-of-day quote | ||
| IM8N | Delayed |
Last Transcript: Insmed Incorporated
| 1 day | +2.62% | ||
| 1 week | +5.90% | ||
| Current month | +7.62% | ||
| 1 month | +22.12% | ||
| 3 months | -2.09% | ||
| 6 months | +11.01% | ||
| Current year | -30.38% |
| 1 week | 113.8 | 121.54 | |
| 1 month | 92.62 | 121.54 | |
| Current year | 90.39 | 186.19 | |
| 1 year | 90.39 | 212.75 | |
| 3 years | 21.92 | 212.75 | |
| 5 years | 16.04 | 212.75 | |
| 10 years | 11.31 | 212.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Will Lewis
CEO | Chief Executive Officer | 57 | 2012-09-09 |
Martina Flammer
CTO | Chief Tech/Sci/R&D Officer | 62 | 2019-12-18 |
Roger Adsett
COO | Chief Operating Officer | 57 | 2019-11-13 |
| Director | Title | Age | Since |
|---|---|---|---|
Melvin Sharoky
CHM | Chairman | 75 | 2009-06-15 |
Will Lewis
CHM | Chairman | 57 | 2018-11-07 |
David Brennan
BRD | Director/Board Member | 72 | 2014-05-28 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/19/26 | Free | Director | 6,139 | 0.0028% | ||
| 10/19/26 | Free | Director | 6,139 | 0.0028% | ||
| 9/9/26 | Sell | Director | -25,000 | 0.0114% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.62% | +5.90% | -37.29% | +386.59% | 26.58B | ||
| -2.69% | -0.48% | +53.97% | +66.82% | 66.33B | ||
| -0.92% | +7.67% | +12.64% | +93.22% | 60.62B | ||
| 0.00% | +0.39% | +22.34% | +89.58% | 55.5B | ||
| +0.14% | +2.35% | +13.86% | +111.94% | 47.58B | ||
| -2.21% | -2.47% | +20.18% | +28.81% | 43.69B | ||
| -2.30% | -10.40% | +154.30% | +707.36% | 37.27B | ||
| +2.15% | +1.42% | +14.58% | +48.71% | 36.57B | ||
| -2.32% | -2.24% | +76.50% | +56.02% | 32.22B | ||
| -0.77% | -5.11% | +43.45% | -2.79% | 24.45B | ||
| Average | -0.62% | -0.14% | +37.45% | +158.63% | 43B | |
| Weighted average by Cap. | -0.82% | +0.08% | +37.02% | +143.44% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.86B 1.69B 1.56B 1.41B 2.65B 176B 2.75B 18.74B 7.43B 93.75B 6.99B 6.84B 298B | 2.99B 2.71B 2.51B 2.26B 4.26B 282B 4.42B 30.13B 11.95B 151B 11.23B 10.99B 478B |
| Net income | -357M -324M -300M -270M -509M -33.69B -527M -3.6B -1.43B -18B -1.34B -1.31B -57.13B | 167M 152M 140M 127M 239M 15.79B 247M 1.69B 668M 8.43B 628M 615M 26.77B |
| Net Debt | -514M -466M -431M -389M -733M -48.51B -759M -5.18B -2.05B -25.91B -1.93B -1.89B -82.25B | -949M -860M -795M -718M -1.35B -89.48B -1.4B -9.56B -3.79B -47.8B -3.56B -3.49B -152B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-13 | US$121.16 | +2.62% | 1,543,624 |
| 26-11-12 | US$118.07 | -2.22% | 2,397,944 |
| 26-11-11 | US$120.75 | +1.05% | 1,488,927 |
| 26-11-10 | US$119.49 | +2.92% | 3,346,741 |
| 26-11-09 | US$116.10 | +1.48% | 2,668,854 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- INSM Stock
Select your edition
All financial news and data tailored to specific country editions
















